Related Experiment Videos

Expression of multidrug resistance-associated protein (MRP) in anaplastic carcinoma of the thyroid

I Sugawara1, T Arai, T Yamashita

  • 1Department of Pathology, Saitama Medical School, Japan.

Cancer Letters
|July 29, 1994
PubMed

Insights

Anaplastic thyroid carcinoma shows poor prognosis. Multidrug resistance-associated protein (MRP) mRNA expression is high in these tumors, suggesting its role in anti-cancer drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Anaplastic thyroid carcinoma (ATC) has a very poor prognosis despite therapeutic efforts.
  • The mechanisms of anti-cancer drug resistance in ATC are not fully understood.
  • P-glycoprotein (mdr1) expression alone does not explain drug resistance in ATC.

Purpose of the Study:

  • To investigate the role of multidrug resistance-associated protein (MRP) mRNA expression in ATC.
  • To elucidate the mechanisms of anti-cancer drug resistance in anaplastic thyroid carcinoma.

Main Methods:

  • Quantitative analysis of MRP mRNA expression in 11 ATC tissue samples.
  • Analysis of MRP mRNA expression in 8 ATC cell lines.

Main Results:

  • High MRP mRNA expression was detected in 7 out of 11 (63.6%) ATC tissue samples.
  • All 8 (100%) ATC cell lines exhibited high MRP mRNA expression.

Conclusions:

  • MRP mRNA expression is frequently elevated in anaplastic thyroid carcinoma.
  • This finding suggests that MRP plays a significant role in the drug resistance observed in ATC.
  • Further research into MRP inhibition could offer new therapeutic strategies for ATC.

Related Concept Videos